Phathom Pharmaceuticals

Going beyond to advance treatments for patients with acid-related disorders. (Nasdaq: $PHAT)

[Phathom Pharmaceuticals @phathompharma]

One hour to go! Tune in today at 12:15 PM EDT to hear from members of the $PHAT management team during a Fireside Chat at the Jefferies Global Healthcare Conference. Click here for the live discussion or to watch the recording after:
https://t.co/dI5yX5wrii

[Phathom Pharmaceuticals @phathompharma]

How will AI shape the future of pharma field engagement?

$PHAT’s SVP, Sales, Jonathan Bentley, shares his perspective on using AI to empower field teams while preserving the human connection that drives meaningful HCP engagement in this Kinara feature.

Read more: https://t.co/tBEHiDNQrM

[Phathom Pharmaceuticals @phathompharma]

Big welcome to our 2026 Summer Interns!

They’ll spend the summer jumping into projects across IT, Finance, and Analytics, bringing fresh ideas, energy, and curiosity to the team.

Proud to welcome students from @RutgersU, @JohnsHopkins, and @NJIT.

Welcome to the #PhathomPhamily! #LifeAtPhathom

[Phathom Pharmaceuticals @phathompharma]

$PHAT management will participate in several upcoming investor conferences throughout May and June. Tune in to hear the latest: https://t.co/RX8TPQWyqk

[Phathom Pharmaceuticals @phathompharma]

This #MemorialDay, we honor and remember the courageous service members who made the ultimate sacrifice for our country. Phathom’s offices will be closed in observance of the holiday.

[Phathom Pharmaceuticals @phathompharma]

Eosinophilic esophagitis (EoE) affects ~1 in 2,000 people in the U.S. and can significantly impact daily life. On #EoEDay, we highlight the critical need for continued research.

Learn more about our clinical trial: https://t.co/njIdhPgIIp

#EoEAwareness #UniteforEoE #APFED

[Phathom Pharmaceuticals @phathompharma]

#NEWS $PHAT highlights the breadth of clinical and scientific research on vonoprazan presented at #DDW2026, reflecting growing scientific interest.

Read more: https://t.co/uy5DmFHh0S

[Phathom Pharmaceuticals @phathompharma]

On World Eosinophilic Diseases Day, we recognize the patient community and raise even greater awareness of these conditions.

@APFEDorg’s Executive Director Mary Jo Strobel shares her perspective to help bring greater visibility.

#EosinophilicDiseasesDay #EosAware

[Phathom Pharmaceuticals @phathompharma]

Greater awareness of eosinophilic diseases can help drive earlier diagnosis and better outcomes. Ahead of #NEAW, we recognize @APFEDorg and the advocates supporting patients. Learn more and get involved:
https://t.co/qNtvC23EHK

#EosAware

[Phathom Pharmaceuticals @phathompharma]

Many eosinophilic diseases are underdiagnosed or misdiagnosed, with some patients waiting years for answers.

Follow along this month as we support @APFEDorg’s awareness efforts and share more about these conditions and their impact.

[Phathom Pharmaceuticals @phathompharma]

Seven years of building, growing, and making an impact! We’re celebrating $PHAT’s 7th anniversary and the journey from early innovation to a commercial-stage organization, powered by our #PhathomPhamily. Thank you to our employees, partners, HCPs, patients, and shareholders for your continued support as we build a leading #GI company.

[Phathom Pharmaceuticals @phathompharma]

#DDW2026 was an exciting week for the GI community. Hear from our CEO Steve Basta as he shares key takeaways and how Phathom is building momentum to better serve #GI patients.

[Phathom Pharmaceuticals @phathompharma]

Join us TODAY for a live product theater and learn about our novel treatment option for adults with #GERD. See you there!
#DDW2026

[Phathom Pharmaceuticals @phathompharma]

We’re looking forward to joining the GI community in Chicago for #DDW2026. Read our press release to learn more about our presence and stop by booth 2511 to meet members of our team: https://t.co/8Eznk1nAl4

[Phathom Pharmaceuticals @phathompharma]

#NEWS $PHAT reported Q1 2026 financial results, reflecting strong year-over-year growth. Learn more: https://t.co/sO2XbY7nBY

[Phathom Pharmaceuticals @phathompharma]

Join us on Monday, May 4 at 12:00 pm CDT for a live product theater presentation at #DDW2026 to learn more about the clinical efficacy and safety profile of VOQUEZNA® (vonoprazan).

[Phathom Pharmaceuticals @phathompharma]

#WereHiring! Meet the #PhathomPhamily at #DDW2026 in Chicago (booth 2511) and discover how you can make an impact in #GI care. Explore our culture and open roles here: https://t.co/Zjar3dXPB4

[Phathom Pharmaceuticals @phathompharma]

Proud to see $PHAT’s Nancy Phelan, SVP, Marketing & Analytics, join an upcoming @ThinkDHC webinar exploring the future of point-of-care (POC) marketing and patient engagement.

To hear Nancy’s perspective, register to join the discussion: https://t.co/KzCCuXALIz

[Phathom Pharmaceuticals @phathompharma]

Every 40 minutes, someone in the U.S. is diagnosed with esophageal cancer & it remains the 7th leading cause of cancer death among U.S. men.

Know the potential symptoms which may include: difficulty swallowing, persistent heartburn, chest discomfort, or unexplained weight loss. If you have questions or concerns, talk to a healthcare provider.

#EsophagealCancerAwarenessMonth with @ECActionNetwork and @ECAware. Learn more: https://t.co/3LUkws8OWT

[Phathom Pharmaceuticals @phathompharma]

Phathom is headed to the Windy City! Join us at #DDW2026 and stop by booth 2511 to learn more about our innovative GI treatments and how we’re supporting patients, providers, and the broader #GI community.